GlassScriptPhysician profile
Steven R Quam
NPI 1780681551
$1,288.49
in general payments reported to CMS, 2019-2025
20 companies · $196 in 2025
The $196 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $512 · 2020: $165 · 2021: $46.16 · 2022: $172 · 2023: $75.94 · 2024: $121 · 2025: $196.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $393.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $392.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $324.42 | 2019-2022 | |
| Vertex Pharmaceuticals Incorporated | $193.08 | 2024-2025 | |
| Pfizer INC. | $156.76 | 2019-2023 | |
| Si-Bone, INC. | $84.31 | 2023-2024 | |
| Supernus Pharmaceuticals, INC. | $81.97 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $81.34 | 2019-2021 | |
| Lilly USA, LLC | $74.41 | 2019-2021 | |
| Amgen INC. | $51.86 | 2019 | |
| Boston Scientific Corporation | $39.89 | 2022 | |
| Tonix Medicines, INC. | $28.24 | 2025 | Tonmya |
| Abbvie INC. | $26.64 | 2024 | |
| Scilex Pharmaceuticals INC. | $20.44 | 2020 | |
| Abbott Laboratories | $19.64 | 2019 | |
| Allergan, INC. | $18.15 | 2019 | |
| Vertos Medical, INC. | $18.10 | 2024 | Mild Device Kit |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company LTD. | $16.69 | 2022 | |
| Collegium Pharmaceutical, INC. | $15.73 | 2022 | |
| Idorsia Pharmaceuticals US INC | $13.29 | 2022 | |
| Vertical Pharmaceuticals, LLC | $12.70 | 2019 | |
| Merck Sharp & Dohme LLC | $10.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Quam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.